Evidence for a common founder effect amongst South African and Zambian individuals with Spinocerebellar ataxia type 7.

J Neurol Sci

Division of Human Genetics, Department of Clinical Laboratory Sciences, Institute of Infectious Disease and Molecular Medicine, Faculty of Heath Sciences, University of Cape Town, Cape Town, South Africa. Electronic address:

Published: July 2015

AI Article Synopsis

  • Spinocerebellar ataxia type 7 (SCA7) is a genetic neurodegenerative disorder caused by a mutation in the ataxin 7 gene, resulting in symptoms like progressive coordination issues and vision problems.
  • While SCA7 is considered rare, there are noted founder effects in regions like South Africa, Scandinavia, and Mexico, indicating specific genetic lineages.
  • This study presents the first identified Zambian families with SCA7, showing that a genetic link exists between Zambian and South African patients, suggesting a shared ancestry in the disease's development.

Article Abstract

Spinocerebellar ataxia type 7 (SCA7) is an inherited neurodegenerative disease caused by the expansion of a CAG repeat within the ataxin 7 gene, leading to a pathogenic polyglutamine tract within the ataxin 7 protein. SCA7 patients suffer from progressive cerebellar ataxia and macular degeneration. SCA7 is considered to be rare, although founder effects have been reported in South Africa, Scandinavia and Mexico. The South African SCA7-associated haplotype has not been investigated in any other populations, and there have been limited reports of SCA7 patients from other African countries. Here, we describe the first two ethnic Zambian families with confirmed SCA7. Haplotype analysis showed that the South African SCA7 haplotype alleles were significantly associated with the pathogenic expansion in affected Zambian individuals, providing strong evidence for a shared founder effect between South African and Zambian SCA7 patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2015.04.053DOI Listing

Publication Analysis

Top Keywords

south african
16
sca7 patients
12
founder south
8
african zambian
8
zambian individuals
8
spinocerebellar ataxia
8
ataxia type
8
sca7 haplotype
8
sca7
7
south
5

Similar Publications

HIV-prevention efforts focusing on women of child-bearing potential are needed to end the HIV epidemic in the African region. The use of antiretroviral drugs as pre-exposure prophylaxis (PrEP) is a critical HIV prevention tool. However, safety data on new antiretrovirals during pregnancy are often limited because pregnant people are excluded from drug development studies.

View Article and Find Full Text PDF

Mpox, formerly referred to as monkeypox, is a viral disease endemic to central Africa, resulting from the monkeypox virus (MPXV). This study provides a current overview of the Mpox epidemic as of 2024, emphasizing significant developments and epidemiological trends. The World Health Organization (WHO) initially designated a clade Ⅱb outbreak as a global health emergency in May 2022, which was subsequently managed through vaccination and public health interventions by May 2023.

View Article and Find Full Text PDF

Killer whales () have been documented to prey on white sharks (), in some cases causing localised shark displacement and triggering ecological cascades. Notably, a series of such predation events have been reported from South Africa over the last decade, with killer whales specifically targeting sharks' liver. However, observations of these interactions are rare, and knowledge of their frequency across the world's oceans remains limited.

View Article and Find Full Text PDF

Introduction: African swine fever is a highly transmissible and lethal infectious disease caused by the African swine fever virus (ASFV), which has considerably impacted the global swine industry. Lipid metabolism plays a vital role in sustaining lipid and energy homeostasis within cells and influences the viral life cycle.

Methods And Results: In this study, we found that ASFV infection disrupts lipid metabolism in the host.

View Article and Find Full Text PDF

Background: Research on the contextual drivers of antimicrobial stewardship (AMS) programme interventions in neonatal units is limited.

Methods: As part of a prospective mixed-methods multidisciplinary neonatal AMS (NeoAMS) interventional study in 14 South African hospitals, we applied a three-phased process to assess implementation barriers and contextual drivers experienced by participating health professionals. The study included: (Phase one; P1) a survey of pre-intervention barriers and enablers; (P2) written feedback during the study intervention phase; and (P3) semi-structured exit interviews.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!